Benutzer: Gast  Login
Titel:

Current status of financing and reimbursement of trastuzumab (Herceptin (R)) for adjuvant and advanced therapy of breast cancer in Germany

Dokumenttyp:
Review
Autor(en):
Jacobs, VR
Abstract:
Trastuzumab (Herceptin) is a monoclonal antibody treatment option for breast cancer patients costing up to 5-10 times more than state-of-the-art chemotherapy. A significantly improved outcome for defined groups of patients who are HER2/neu-positive was previously shown for advanced/metastatic breast cancer and recently also for adjuvant therapy in several large phase III trials. However, financial limitations of any health system, even in wealthy nations such as Germany, can prevent optimal trea...     »
Zeitschriftentitel:
Breast Care (Basel)
Jahr:
2006
Band / Volume:
1
Heft / Issue:
2
Seitenangaben Beitrag:
86-94
Sprache:
eng
Print-ISSN:
1661-3791
TUM Einrichtung:
Frauenklinik und Poliklinik
 BibTeX